K Number
K111972
Device Name
AFFINITY CP CENTRIFUGAL PUMP, RESTING HEART SYS.,MYOTHERM CARDIOPLEGIA DELIV.,AFFINITY HOLLOW FIBER OXYGENATOR,AAF
Manufacturer
Date Cleared
2011-07-27

(16 days)

Regulation Number
870.4360
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
In general, these devices are intended for use during cardiopulmonary bypass surgery for up to 6 hours. No changes were made to the intended use of the individual devices. The Affinity CP Centrifugal Blood Pump with Carmeda BioActive Surface is used to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to 6 hours). It is also indicated for use in extracorporeal support systems (for periods up to 6 hours) not requiring complete cardiopulmonary bypass (eg, valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants). The MYOtherm XP is a device intended for the mixing, warming/ cooling and delivery of oxygenated blood/cardioplegia solution in a predetermined ratio. The Affinity Arterial Filter is indicated for use in cardiopulmonary bypass procedures up to 6 hours in duration for the removal of particulate and gaseous microemboli. The Affinity NT Hollow Fiber Oxygenator with Plasma Resistant Fiber is intended to be used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood and to cool or warm the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration. The AFFINITY NT Integrated CVR Membrane Oxygenator (Plasma Resistant Fiber [PRF] Oxygenator) is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood, cool or warm the blood and oxygenate and remove carbon dioxide from the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration. This product, MVR Collapsible Venous Reservoir Bag, is indicated for use during cardiopulmonary bypass surgery in an extracorporeal circuit utilizing a membrane oxygenator. The MVR Holder (Model MVR-SH) is indicated for use with the MVR Collapsible Venous Reservoir Bag. Medtronic Coated Accessories (Flow Probes) is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery. Medtronic Coated Accessories (Tri-Optic Measurement Cells) is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery. Medtronic Packs and Accessories (Tubing and Connectors) is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery. The Medtronic Resting Heart Module is indicated for use in surgical procedures requiring extracorporeal circulatory support, gas exchange, and thermal regulation. The device is indicated for use in procedures requiring blood flow rate of 1-6 lpm and lasting up to six hours. The system is indicated for use only with the Bio-Console. The VARD is indicated for use only with the AAR1000. The Bio-Pump+ Blood Pump in the Medtronic Resting Heart Module is indicated for use only with the Bio-Console. The Carmeda AFFINITY NT Oxygenator and Carmeda AFFINITY Arterial Filter in the Medtronic Resting Heart Module have the same indications for use as a Carmeda AFFINITY NT Oxygenator and Carmeda AFFINITY Arterial Filter used in other extracorporeal circuits. Medtronic DLP "Y" Adapter - Coronary Perfusion is intended for use in conjunction with the delivery of cardioplegia solution. Medtronic DLP Aortic Root Cannula is intended for use in conjunction with cardiopulmonary bypass surgery for delivering cardioplegia solution. The cannula may also be used to aspirate air from the aorta at the conclusion of the bypass procedure. The #23009 cannula may also be used to monitor pressure in the aorta. Medtronic EOPA 3D Arterial Cannula are intended for use in perfusion of the ascending aorta during short term (6 hours or less) cardiopulmonary bypass. Medtronic DLP Single Stage Venous Cannula are intended for collection of venous blood from the right side of the heart via the superior and inferior vena cava during cardiopulmonary bypass surgery up to six hours or less. Medtronic DLP Femoral Arterial and Venous Cannula is intended for rapid femoral venous and arterial access for short term cardiopulmonary bypass.
Device Description
No changes to the devices are being made. An additional source of the raw material used to make USP heparin used in Carmeda and Trillium coatings is being added.
More Information

Not Found

No
The document describes various components used in cardiopulmonary bypass surgery and focuses on changes related to raw material sourcing for coatings. There is no mention of AI, ML, or any related computational techniques.

Yes

The devices described are intended for use in cardiopulmonary bypass surgery, which is a medical procedure used to treat diseases and conditions, thus performing a therapeutic function.

No

The devices described are primarily for circulatory support, blood oxygenation, warming/cooling, and delivery of solutions during cardiopulmonary bypass surgery. While some components might monitor parameters (e.g., pressure), their main function is therapeutic and supportive, not diagnostic (i.e., identifying a disease or condition).

No

The device description and intended use clearly describe physical medical devices used in cardiopulmonary bypass surgery, such as blood pumps, oxygenators, filters, and cannulas. The submission is about a change in raw material for a coating on these physical devices, not a software component.

Based on the provided text, these devices are not IVDs (In Vitro Diagnostics).

Here's why:

  • Intended Use: The intended use of all the listed devices is related to extracorporeal circulation and cardiopulmonary bypass surgery. They are used to pump, oxygenate, filter, warm/cool, and deliver blood or solutions outside the body during surgical procedures.
  • IVD Definition: In vitro diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
  • Lack of Specimen Analysis: None of the descriptions mention the analysis of biological specimens in vitro. Their function is to manage blood flow and composition in an extracorporeal circuit.

Therefore, these devices fall under the category of medical devices used in surgical procedures, not in vitro diagnostics.

N/A

Intended Use / Indications for Use

  • Affinity CP Centrifugal Blood Pump: The Affinity CP Centrifugal Blood Pump with Carmeda BioActive Surface is used to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to 6 hours). It is also indicated for use in extracorporeal support systems (for periods up to 6 hours) not requiring complete cardiopulmonary bypass (eg, valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants).
  • Medtronic MYOtherm XP, Cardioplegia Delivery System: The MYOtherm XP® is a device intended for the mixing, warming/ cooling and delivery of oxygenated blood/cardioplegia solution in a predetermined ratio.
  • Affinity Arterial Filter: The Affinity Arterial Filter is indicated for use in cardiopulmonary bypass procedures up to 6 hours in duration for the removal of particulate and gaseous microemboli.
  • Affinity Hollow Fiber Oxygenator with Plasma Resistant Fiber: The Affinity NT Hollow Fiber Oxygenator with Plasma Resistant Fiber is intended to be used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood and to cool or warm the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.
  • Affinity NT Integrated CVR Membrane Oxygenator: The AFFINITY® NT Integrated CVR Membrane Oxygenator (Plasma Resistant Fiber [PRF] Oxygenator) is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood, cool or warm the blood and oxygenate and remove carbon dioxide from the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.
  • MVR Collapsible Venous Reservoir Bag: This product, is indicated for use during cardiopulmonary bypass surgery in an extracorporeal circuit utilizing a membrane oxygenator. The MVR® Holder (Model MVR-SH) is indicated for use with the MVR® Collapsible Venous Reservoir Bag.
  • Medtronic Coated Accessories (Flow Probes): This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
  • Medtronic Coated Accessories (Tri-Optic Measurement Cells): This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
  • Medtronic Packs and Accessories (Tubing and Connectors): This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.
  • Medtronic Resting Heart System: The Medtronic® Resting Heart™ Module is indicated for use in surgical procedures requiring extracorporeal circulatory support, gas exchange, and thermal regulation. The device is indicated for use in procedures requiring blood flow rate of 1-6 lpm and lasting up to six hours. The system is indicated for use only with the Bio-Console®. The VARD is indicated for use only with the AAR1000. The Bio-Pump+® Blood Pump in the Medtronic® Resting Heart™ Module is indicated for use only with the Bio-Console®. The Carmeda® AFFINITY® NT Oxygenator and Carmeda® AFFINITY® Arterial Filter in the Medtronic® Resting Heart™ Module have the same indications for use as a Carmeda® AFFINITY® NT Oxygenator and Carmeda® AFFINITY® Arterial Filter used in other extracorporeal circuits.
  • Medtronic DLP "Y" Adapter - Coronary Perfusion: This adapter is intended for use in conjunction with the delivery of cardioplegia solution.
  • Medtronic DLP Aortic Root Cannula: This cannula is intended for use in conjunction with cardiopulmonary bypass surgery for delivering cardioplegia solution. The cannula may also be used to aspirate air from the aorta at the conclusion of the bypass procedure. The #23009 cannula may also be used to monitor pressure in the aorta.
  • Medtronic EOPA 3D Arterial Cannula: These cannulae are intended for use in perfusion of the ascending aorta during short term (6 hours or less) cardiopulmonary bypass.
  • Medtronic DLP Single Stage Venous Cannula: These cannulae are intended for collection of venous blood from the right side of the heart via the superior and inferior vena cava during cardiopulmonary bypass surgery up to six hours or less.
  • Medtronic DLP Femoral Arterial and Venous Cannula: This cannula is intended for rapid femoral venous and arterial access for short term cardiopulmonary bypass.

Product codes (comma separated list FDA assigned to the subject device)

KFM, DTR, DTM, DTZ, DTN, DPT, DRY, DWF, DTL

Device Description

No changes to the devices are being made. An additional source of the raw material used to make USP heparin used in Carmeda and Trillium coatings is being added.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Bench testing was used to establish the interchangeability of the two sources of raw material for USP heparin used in Carmeda and Trillium coating. Animal and human clinical testing was not required to establish substantial equivalence. The following performance tests were conducted:

  • Coating testing
  • Potency of Heparin
  • Chemistry testing
    Testing demonstrates that there is no coating performance difference between the two sources of raw material for heparin.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K852807, K973011, K050109, K111658, K003724, K011864, K000379, K013084, K033468, K071253, K933586, K973760, K000430, K926226, K936003, K021287, K920774, K830858, K012747, K910421, K012743, K891687, K902845, K012538, K031700, K790563, K790564, K791498, K841482, K850385, K790565, K810548, K834039, K865079, K840001, K840002, K031037, K031518, K033416, K043179, K061254, K841275, K845045, K031776, K031827, K033264, K052372, K872033, K875353, K884129, K915268, K924642, K052524

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 870.4360 Nonroller-type blood pump.

(a)
Nonroller-type cardiopulmonary and circulatory bypass blood pump —(1)Identification. A nonroller-type cardiopulmonary and circulatory bypass blood pump is a prescription device that uses a method other than revolving rollers to pump the blood through an extracorporeal circuit for periods lasting less than 6 hours for the purpose of providing either:(i) Full or partial cardiopulmonary bypass (
i.e., circuit includes an oxygenator) during open surgical procedures on the heart or great vessels; or(ii) Temporary circulatory bypass for diversion of flow around a planned disruption of the circulatory pathway necessary for open surgical procedures on the aorta or vena cava.
(2)
Classification —Class II (special controls). The special controls for this device are:(i) Non-clinical performance testing must perform as intended over the intended duration of use and demonstrate the following: Operating parameters, dynamic blood damage, heat generation, air entrapment, mechanical integrity, and durability/reliability;
(ii) The patient-contacting components of the device must be demonstrated to be biocompatible;
(iii) Sterility and shelf life testing must demonstrate the sterility of patient-contacting components and the shelf life of these components; and
(iv) Labeling must include information regarding the duration of use, and a detailed summary of the device- and procedure-related complications pertinent to use of the device.
(b)
Nonroller-type temporary ventricular support blood pump —(1)Identification. A nonroller-type temporary ventricular support blood pump is a prescription device that uses any method resulting in blood propulsion to provide the temporary ventricular assistance required for support of the systemic and/or pulmonary circulations during periods when there is ongoing or anticipated hemodynamic instability due to immediately reversible alterations in ventricular myocardial function resulting from mechanical or physiologic causes. Duration of use would be less than 6 hours.(2)
Classification. Class III (premarket approval).(c)
Date premarket approval application (PMA) or notice of completion of product development protocol (PDP) is required. A PMA or notice of completion of a PDP is required to be filed with FDA on or before September 8, 2015, for any nonroller-type temporary ventricular support blood pump that was in commercial distribution before May 28, 1976, or that has, on or before September 8, 2015, been found to be substantially equivalent to any nonroller-type temporary ventricular support blood pump that was in commercial distribution before May 28, 1976. Any other nonroller-type temporary ventricular support blood pump shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.

0

111912

JUL 2 7 2011

2 510(k) Summary

The following page contains the 510(k) Summary.

1

K III 972

Image /page/1/Picture/1 description: The image shows the Medtronic logo. On the left is a circular emblem with a figure in motion, possibly representing a person exercising or undergoing rehabilitation. To the right of the emblem is the word "Medtronic" in a bold, stylized font. The logo appears to be a representation of the company's focus on medical technology and improving health outcomes.

510(k) Summary

Date Prepared:July 6, 2011
Submitter:Medtronic
7611 Northland Drive
Minneapolis, MN 55428
Establish Registration Number: 2184009
Contact Person:Jessica Sixberry
Senior Regulatory Affairs Specialist
Phone: (763) 514-9849
Fax: (651) 367-1893
Email: jessica.m.sixberry@medtronic.com

Device Name and Classification:

Product Family:Centrifugal Blood Pumps
Trade Name:Affinity Blood Pumps, Bio-Pumps
Common Name:Centrifugal Blood Pump
Regulation Number:870.4360
Product Code:KFM
Classification:Class III
Classification Name:Pump, Blood, Cardiopulmonary Bypass, Non-Roller Type
Product Family:MYOtherm Cardioplegia Delivery Systems
Trade Name:MYOtherm Cardioplegia Delivery Systems
Common Name:Cardioplegia Delivery
Regulation Number:870.4240
Product Code:DTR
Classification:Class II
Classification Name:Heat-Exchanger, Cardiopulmonary Bypass
Product Family:Arterial Blood Filters
Trade Name:Affinity Arterial Filters
Common Name:Arterial Blood Filters
Regulation Number:870.4260
Product Code:DTM
Classification:Class II
Classification Name:Filter, Blood, Cardiopulmonary Bypass, Arterial Line

Product Family: Oxygenators

Alleviating Pain · Restoring Health · Extending Life

2

のお気になる。

Product Family:Oxygenators
Trade Name:Affinity NT Hollow Fiber Oxygenator with Plasma Resistant Fiber,
Minimax Plus Oxygenator
Common Name:Hollow Fiber Oxygenators
Regulation Number:870.4350
Product Code:DTZ
Classification:Class II
Classification Name:Oxygenator, Cardiopulmonary Bypass

.. . . .

September 1998 - 1999 - 1999

*** -

Product Family:Cardiotomy/Venous Reservoirs
Trade Name:Affinity Cardiotomy/Venous Reservoirs
Common Name:Cardiotomy/Venous Reservoir
Regulation Number:870.4400
Product Code:DTN
Classification:Class II
Classification Name:Reservoir, Blood, Cardiopulmonary Bypass
Product Family:Venous Reservoir Bags
Trade Name:MVR Collapsible Venous Reservoir Bag
Common Name:Venous Reservoir Bag
Regulation Number:870.4400
Product Code:DTN
Classification:Class II
Classification Name:Reservoir, Blood, Cardiopulmonary Bypass
Product Family:Flow Probes
Trade Name:Bio-Probe Flow Probe
Common Name:Flow Probe
Regulation Number:870.2120
Product Code:DPT
Classification:Class II
Classification Name:Probe, Blood-Flow, Extravascular
Product Family:Tri-Optic Measurement Cells
Trade Name:Tri-Optic Measurement Cells
Common Name:Tri-Optic Measurement Cells
Regulation Number:870.4330
Product Code:DRY
Classification:Class II
Classification Name:Monitor, Blood-Gas, On-line, Cardiopulmonary Bypass
Product Family:Tubing and Connectors
----------------------------------------

3

K111912

.

Product Family:Tubing and Connectors
Trade Name:Extracorporeal Circuit Tubing and Connectors
Common Name:Tubing and Connectors
Regulation Number:870.4210
Product Code:DWF
Classification:Class II
Classification Name:Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass
Product Family:Resting Heart System
Trade Name:Resting Heart System
Common Name:Low Prime Extracorporeal Circuit
Regulation Number:870.4400
870.4290
Product Code:DTN
DTL
Classification:Class II
Classification Name:Reservoir, blood, Cardiopulmonary Bypass
Adapter, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass
Product Family:Cardioplegia Adapters
Trade Name:DLP Cardioplegia Adapters
Common Name:Cardioplegia Adapters
Regulation Number:870.7290
Product Code:DTL
Classification:Class II
Classification Name:Adapter, Stopcock, Manifold, Fitting, Cardiopulmonary Bypass
Product Family:Aortic Root Cannula
Trade Name:DLP Aortic Root Cannula
Common Name:Aortic Root Cannula
Regulation Number:870.4210
Product Code:DWF
Classification:Class II
Classification Name:Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass
Product Family:Arterial Cannula
Trade Name:DLP, Select, EOPA Arterial Cannula
Common Name:Arterial Return Cannula
Regulation Number:870.4210
Product Code:DWF
Classification:Class II
Classification Name:Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass

.

·

4

.. . . . . :

Product Family:Venous Cannula
Trade Name:DLP, MC2, MC2X, Single Stage, Two Stage, Three Stage Cannula
Common Name:Venous Cannula
Regulation Number:870.4210
Product Code:DWF
Classification:Class II
Classification Name:Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass
Product Family:Femoral Cannula
Trade Name:DLP and Bio-Medicus, Femoral Arterial and Femoral Venous Cannula
Common Name:Femoral Cannula
Regulation Number:870.4210
Product Code:DWF
Classification:Class II
Classification Name:Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass

:

Predicate Devices

Product Family:Associated 510(k)s
Centrifugal Blood
PumpsK852807, K973011, K050109, K111658
MYOtherm
Cardioplegia
Delivery SystemsK003724, K011864
Arterial Blood FiltersK000379, K013084, K033468, K071253
OxygenatorsK933586, K973760, K000430
Cardiotomy/Venous
ReservoirsK926226, K936003, K021287
Venous Reservoir
BagsK920774
Flow ProbesK830858, K012747
Tri-Optic
Measurement CellsK910421, K012743
Tubing and
ConnectorsK891687, K902845, K012538
Resting Heart
SystemK031700
Cardioplegia
AdaptersK790563, K790564, K791498, K841482, K850385
Aortic Root CannulaK790565, K810548, K834039, K865079
Arterial CannulaK840001, K840002, K031037, K031518, K033416, K043179,
K061254

5

Product Family:Associated 510(k)s
Venous CannulaK841275, K845045, K031776, K031827, K033264, K052372
Femoral CannulaK872033, K875353, K884129, K915268, K924642, K052524

Device Description

No changes to the devices are being made. An additional source of the raw material used to make USP heparin used in Carmeda and Trillium coatings is being added.

Indications for Use

In general, these devices are intended for use during cardiopulmonary bypass surgery for up to 6 hours. No changes were made to the intended use of the individual devices.

Comparison to Predicate Devices

  • Intended Use: All devices have the same intended use as their predicate devices. .
  • Principles of Operation and Technology: All devices have the same principle of . operation and technology as their predicate devices
  • Performance: Testing demonstrates that there is no coating performance difference . between the two sources of raw material for heparin.
  • Suppliers: The supplier of USP heparin remains the same. A new source of raw material . is being added.

Summary of Performance Data

Bench testing was used to establish the interchangability of the two sources of raw material for USP heparin used in Carmeda and Trillium coating. Animal and human clinical testing was not required to establish substantial equivalence. The following performance tests were conducted:

  • . Coating testing
  • Potency of Heparin .
  • . Chemistry testing

Conclusion

Medtronic has demonstrated that the new source of raw material for heparin is interchangeable with the current source of raw material for heparin based upon testing results. Therefore, the Carmeda and Trillium coated devices are substantially equivalent to the existing, predicate devices.

6

Image /page/6/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle-like symbol with three curved lines representing the body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Medtronic Perfusion System c/o Ms. Jessica Sixberry Senior Regulatory Affairs Specialist 7611 Northland Drive Minneapolis, MN 55428

JUL 2 7 2011

Re: K111972

Affinity Blood Pumps, Bio-Pumps Regulation Number: 21 CFR 870.4360 Regulation Name: Non-roller type cardiopulmonary blood pump Regulatory Class: Class III (three) Product Code: KFM, DTR, DTM, DTZ, DTN, DPT, DRY, DWF, DTL Dated: July 7, 2011 Received: July 11, 2011

Dear Ms. Sixberry:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

7

Page 2 - Ms. Jessica Sixberry

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

K

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

8

1 Statement of Indications for Use

The following page contains a representative 'indications for use' statement from each of the associated families that are included in this change. The following is a list of the associated families of Medtronic devices:

  • . Centrifugal Blood Pumps
  • MYOtherm Cardioplegia Delivery Systems .
  • Arterial Blood Filters .
  • . Oxygenators :
  • . Cardiotomy/Venous Reservoirs
  • Venous Reservoir Bags .
  • Flow Probes .
  • . Tri-Optic Measurement Cells
  • . Tubing and Connectors
  • . Resting Heart System
  • . Cardioplegia Adapters
  • . Aortic Root Cannula
  • . Arterial Cannula
  • Venous Cannula .
  • Femoral Cannula ●

9

KIJ1972 510(k) Number (if known): _

Device Name: Affinity CP Centrifugal Blood Pump

Indications for Use: The Affinity CP Centrifugal Blood Pump with Carmeda BioActive Surface is used to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to 6 hours).

It is also indicated for use in extracorporeal support systems (for periods up to 6 hours) not requiring completecardiopulmonary bypass (eg, valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants).

Prescription Use X OR Per 21 CFR 801.109

Over-The-Counter Use ...

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

K

(Division Sign-Off) Division of Cardiovascular Devices

510(k) Number K111972

10

Device Name: Medtronic MYOtherm XP, Cardioplegia Delivery System

Indications for Use: The MYOtherm XP® is a device intended for the mixing, warming/ cooling and delivery of oxygenated blood/cardioplegia solution in a predetermined ratio.

Device Name: Affinity Arterial Filter

Indications for Use: The Affinity Arterial Filter is indicated for use in cardiopulmonary bypass procedures up to 6 hours in duration for the removal of particulate and gaseous microemboli.

Device Name: Affinity Hollow Fiber Oxygenator with Plasma Resistant Fiber

Indications for Use: The Affinity NT Hollow Fiber Oxygenator with Plasma Resistant Fiber is intended to be used in an extracorporeal perfusion circuit to oxygenate and remove carbon dioxide from the blood and to cool or warm the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.

Device Name: Affinity NT Integrated CVR Membrane Oxygenator

Indications for Use: The AFFINITY® NT Integrated CVR Membrane Oxygenator (Plasma Resistant Fiber [PRF] Oxygenator) is intended to be used in an extracorporeal perfusion circuit to collect venous and cardiotomy suctioned blood, cool or warm the blood and oxygenate and remove carbon dioxide from the blood during routine cardiopulmonary bypass procedures up to 6 hours in duration.

Device Name: MVR Collapsible Venous Reservoir Bag

Indications for Use: This product, is indicated for use during cardiopulmonary bypass surgery in an extracorporeal circuit utilizing a membrane oxygenator. The MVR® Holder (Model MVR-SH) is indicated for use with the MVR® Collapsible Venous Reservoir Bag.

Device Name: Medtronic Coated Accessories (Flow Probes)

Indications for Use: This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.

Device Name: Medtronic Coated Accessories (Tri-Optic Measurement Cells)

Indications for Use: This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.

11

Device Name: Medtronic Packs and Accessories (Tubing and Connectors)

Indications for Use: This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery.

Device Name: Medtronic Resting Heart System

Indications for Use: The Medtronic® Resting Heart™ Module is indicated for use in surgical procedures requiring extracorporeal circulatory support, gas exchange, and thermal regulation. The device is indicated for use in procedures requiring blood flow rate of 1-6 lpm and lasting up to six hours. The system is indicated for use only with the Bio-Console®. The VARD is indicated for use only with the AAR1000. The Bio-Pump+® Blood Pump in the Medtronic® Resting Heart™ Module is indicated for use only with the Bio-Console®. The Carmeda® AFFINITY® NT Oxygenator and Carmeda® AFFINITY® Arterial Filter in the Medtronic® Resting Heart™ Module have the same indications for use as a Carmeda® AFFINITY® NT Oxygenator and Carmeda® AFFINITY® Arterial Filter used in other extracorporeal circuits.

Device Name: Medtronic DLP "Y" Adapter - Coronary Perfusion

Indications for Use: This adapter is intended for use in conjunction with the delivery of cardioplegia solution.

Device Name: Medtronic DLP Aortic Root Cannula

Indications for Use: This cannula is intended for use in conjunction with cardiopulmonary bypass surgery for delivering cardioplegia solution. The cannula may also be used to aspirate air from the aorta at the conclusion of the bypass procedure. The #23009 cannula may also be used to monitor pressure in the aorta.

Device Name: Medtronic EOPA 3D Arterial Cannula

Indications for Use: These cannulae are intended for use in perfusion of the ascending aorta during short term (6 hours or less) cardiopulmonary bypass.

Device Name: Medtronic DLP Single Stage Venous Cannula

Indications for Use: These cannulae are intended for collection of venous blood from the right side of the heart via the superior and inferior vena cava during cardiopulmonary bypass surgery up to six hours or less.

12

Device Name: Medtronic DLP Femoral Arterial and Venous Cannula

Indications for Use: This cannula is intended for rapid femoral venous and arterial access for short term cardiopulmonary bypass.

:

·

公司